| Drug Name |
Lutropin alfa |
| Drug ID |
BADD_D01332 |
| Description |
Lutropin alfa is a recombinant human luteinizing hormone produced in yeast with 2 subunits, alpha = 92 residues, beta = 121 residues. It is a heterodimeric glycoprotein made up of monomeric units. Lutropin alfa was the first and only recombinant human form of luteinizing hormone (LH) developed for use in the stimulation of follicular development. Its pharmacological action mimics the biological activity of endogenous LH; an acute rise of LH, or LH surge, in females triggers ovulation and the development of the corpous luteum. In males, LH stimulates Leydig cell to produce testosterone. |
| Indications and Usage |
For treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency (LH <1.2 international units [IU]/L) |
| Marketing Status |
approved |
| ATC Code |
G03GA07 |
| DrugBank ID |
DB00044
|
| KEGG ID |
D04824
|
| MeSH ID |
D007986
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0Z2CM
|
| NDC Product Code |
Not Available |
| UNII |
3JGY52XJNA
|
| Synonyms |
Luteinizing Hormone | Hormone, Luteinizing | Lutropin | LH (Luteinizing Hormone) | ICSH (Interstitial Cell Stimulating Hormone) | Interstitial Cell-Stimulating Hormone | Hormone, Interstitial Cell-Stimulating | Interstitial Cell Stimulating Hormone | Luteozyman | Luteoziman |
